Vicore Pharma AB (6Y4.STU) Q2 2026 Earnings

6MayConfirmed
Q2 2026
-0.04
-0.04
-0.04
-0.03

Details

Expected EPS
-0.042972096
Actual EPS
-0.034914828
Surprise EPS
0.01
Surprise Percent
+18.75%

Description

Vicore Pharma AB (6Y4.STU) has reported earnings of -0.034914828 per share for Q2 2026.

0 Comments

Share your thoughts